Please login or register to print this page.

The British Journal
of Cardiology

This website is intended for healthcare professionals only

2004, Volume 11, Issue 02, pages 81-168

CLINICAL ARTICLE
Br J Cardiol 2004;11:162-8

Cardiac rehabilitation in the UK 2000 – can the National Service Framework milestones be attained?

Cardiac rehabilitation offers physical, psychological and survival benefits for patients recovering from cardiac illness. This questionnaire survey of all known cardiac rehabilitation units in the

Read More

CLINICAL ARTICLE
Br J Cardiol 2004;11:158-60

Antiplatelet therapy – the education gap

There is a widespread lack of awareness amongst the British public of the link between myocardial infarction and stroke, and about secondary

Read More

CLINICAL ARTICLE
Br J Cardiol 2004;11:156-7

Neurogenic atrial fibrillation

Atrial fibrillation (AF) is the commonest sustained arrhythmia encountered in clinical practice. Depending upon its time course, AF can be classified into three categories: paroxysmal,

Read More

CLINICAL ARTICLE
Br J Cardiol 2004;11:148-55

Efficacy and safety of fluvastatin ER 80 mg compared with fluvastatin IR 40 mg in the treatment of primary hypercholesterolaemia

The efficacy and safety of once- or twice-daily immediate-release (IR) fluvastatin 40 mg were compared with those of the extended-release (XL) formulation of fluvastatin 80

Read More

CLINICAL ARTICLE
Br J Cardiol 2004;11:144-7

Thermography of the human arterial system

One of the main targets of current research in cardiology is a diagnostic modality able not only to identify vulnerable atherosclerotic lesions but also to

Read More

CLINICAL ARTICLE
Br J Cardiol 2004;11:138-43

Will prevention of type 2 diabetes reduce the future burden of cardiovascular disease? The evidence base today

The prevalence of type 2 diabetes is set to double over the next 25 years, leading to substantial morbidity and mortality, particularly from macrovascular diabetic

Read More

CLINICAL ARTICLE
Br J Cardiol 2004;11:129-36

Evolution of the HMG CoA reductase inhibitors (statins) in cardiovascular medicine

Recent trials have broadened the evidence base for statin use. It has now been documented that these drugs are effective agents not only in the

Read More

CLINICAL ARTICLE
Br J Cardiol 2004;11:123-27

Inhibition of the renin-angiotensin system in diabetic patients – beyond HOPE

Treatment to reduce blood pressure is effective in preventing and slowing the progression of the vascular complications of diabetes. Recent studies have suggested that use

Read More

CLINICAL ARTICLE
Br J Cardiol 2004;11:112-7

What’s new in the new British Hypertension Society guidelines for the management of hypertension – BHS IV

The British Hypertension Society (BHS) has recently published its latest guidance for the management of hypertension, BHS-IV.1,2 This article summarises these recommendations and discusses the

Read More

NEWS
Br J Cardiol 2004;11:106-11

Improving secondary prevention of coronary heart disease: using the new GP contract to drive change

This is the final article in a series examining how the Coronary Heart Disease Collaborative (CHDC) supports clinical teams to improve services for coronary heart

Read More

EDITORIAL
Br J Cardiol 2004;11:93

OTC statins – an ethical test case

Statins are currently provided at NHS expense for patients with coronary heart disease (CHD), diabetes and those whose coronary risk is greater than 3% per

Read More

EDITORIAL
Br J Cardiol 2004;11:89-91

OTC statins: the implications for primary prevention in the UK

The difficulty in delivering a viable primary prevention policy has been evident ever since the publication of the National Service Framework for Coronary Heart Disease

Read More

 For healthcare professionals only
BJC Learning gif

Close

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

Find out more about our membership benefits

Close

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.

Find out more about our membership benefits